iNCOVACC NASAL VACCINE

INDIA'S 1st INTRANASAL COVID VACCINE MADE BY BHARAT BIOTECH

Bharat Biotech's intranasal Covid vaccine iNCOVACC has been approved by govt

iNCOVACC is a recombinant replication deficient adenovirus vectored vaccine

It will be administered as a booster dose for those aged 18 years and above

It will be priced at <span class='webrupee'>₹</span>800 for private hospitals & <span class='webrupee'>₹</span>325 for government hospitals

iNCOVACC will be rolled out in the fourth week of January

It is likely to be introduced on the Co-WIN platform on 30 Dec